Charles Schwab’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $604K | Sell |
|
|||||
|
2025
Q2 | $387K | Sell |
|
|||||
|
2025
Q1 | $584K | Sell |
|
|||||
|
2024
Q4 | $720K | Buy |
|
|||||
|
2024
Q3 | $708K | Buy |
|
|||||
|
2024
Q2 | $381K | Sell |
|
|||||
|
2024
Q1 | $578K | Buy |
|
|||||
|
2023
Q4 | $947K | Sell |
|
|||||
|
2023
Q3 | $1.8M | Buy |
|
|||||
|
2023
Q2 | $3.42M | Buy |
|
|||||
|
2023
Q1 | $3.59M | Sell |
|
|||||
|
2022
Q4 | $3.57M | Buy |
|
|||||
|
2022
Q3 | $4M | Buy |
|
|||||
|
2022
Q2 | $1.62M | Sell |
|
|||||
|
2022
Q1 | $3.43M | Buy |
|
|||||
|
2021
Q4 | $3.92M | Buy |
|
|||||
|
2021
Q3 | $3.24M | Buy |
|
|||||
|
2021
Q2 | $10M | Buy |
|
|||||
|
2021
Q1 | $7.87M | Buy |
|
|||||
|
2020
Q4 | $9.12M | Buy |
|
|||||
|
2020
Q3 | $9.7M | Sell |
|
|||||
|
2020
Q2 | $1.98M | Buy |
|
|||||
|
2020
Q1 | $1.39M | Buy |
|
|||||
|
2019
Q4 | $1.33M | Buy |
|
|||||
|
2019
Q3 | $1.53M | Buy |
|
|||||
|
2019
Q2 | $897K | Buy |
|
|||||
|
2019
Q1 | $931K | Buy |
|
|||||
|
2018
Q4 | $550K | Sell |
|
|||||
|
2018
Q3 | $930K | Buy |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|
|||||
|
2018
Q1 | $725K | Buy |
|
|||||
|
2017
Q4 | $969K | Sell |
|
|||||
|
2017
Q3 | $1.66M | Buy |
|
|||||
|
2017
Q2 | $1.03M | Buy |
|
|||||
|
2017
Q1 | $1.03M | Buy |
|
|||||
|
2016
Q4 | $858K | Buy |
|
|||||
|
2016
Q3 | $770K | Buy |
|
|||||
|
2016
Q2 | $1.15M | Buy |
|
|||||
|
2016
Q1 | $624K | Buy |
|
|||||
|
2015
Q4 | $809K | Buy |
|
|||||
|
2015
Q3 | $463K | Buy |
|